Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Berendes, Sima ^a   Adeyemi, Olusegun ^a   Oladele, Edward Adekola ^a,b   Oresanya, Olusola Bukola ^c   Okoh, Festus ^c   Valadez, Joseph J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b Lautech University Teaching Hospital   (Nigeria)

^c National Malaria Control Program Federal Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARSUAMOON; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; DIHYDROARTEMISININ; MALACT; MEFLOQUINE; NEXANATE; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PRACTICE; DRUG MARKETING; DRUG QUALITY; HEALTH CARE AVAILABILITY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MALARIA; MALARIA CONTROL; NIGERIA; PATENT MEDICINE VENDOR; PHARMACY; PRACTICE GUIDELINE; QUALITY CONTROL; SAMPLE SIZE; SAMPLING ERROR;

ANTIMALARIALS; ARTEMISININS; COMMERCE; DRUG RESISTANCE; GUIDELINES AS TOPIC; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA; NIGERIA; PHARMACIES; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF HEALTH CARE;

ARTESUNATE; PAPAYA MOSAIC VIRUS;

EID: 84866330692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044775     Document Type: Article

References (55)

1. Hetzel M, Dillip A, Lengeler C, Obrist B, Msechu J, et al. (2008) Malaria treatment in the retail sector: Knowledge and practices of drug sellers in rural Tanzania. BMC Public Health 8: 157.
2. Okeke TA, Okeibunor JC, (2010) Rural-urban differences in health-seeking for the treatment of childhood malaria in south-east Nigeria. Health Policy 95: 62-68.
3. World Health Organization (2006) Partnerships for malaria control: engaging the formal and informal private sectors. Geneva.
4. Oladepo O, Kabiru S, Adeoye BW, Oshiname F, Ofi B, et al. (2008) Malaria Treatment in Nigeria: The Role of Patent Medicine Vendors. Future Health Systems (FHS), Innovations for equity. Innovations and knowledge for future health systems for the poor, Policy Brief, March 2008 No (1) (): 1-4.
5. Okeke T, Uzochukwu B, Okafor H, (2006) An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community. Malaria Journal 5: 97.
6. World Health Organization (2010) World malaria report 2010. Geneva: World Health Organization.
7. National Population Commission (NPC) [Nigeria], National Malaria Control Programme (NMCP) [Nigeria], ICF International (2012) Nigeria Malaria Indicator Survey 2010. Abuja, Nigeria: NPC, NMCP, and ICF International.
8. World Health Organization (2001) Antimalarial drug combination therapy: report of a WHO technical consultation. Geneva: World Health Organization.
9. Akuse RM, Eseigbe EE, Ahmed A, Brieger WR, (2010) Patent medicine sellers: How can they help control childhood malaria? Malaria Research and Treatment(2010): pp. 7 pages.
10. Uzochukwu BS, Onwujekwe EO, Onoka CA, Ughasoro MD, (2008) Rural-urban differences in maternal responses to childhood fever in South East Nigeria. PLoS One 3: e1788.
11. Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA, (2004) Interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Policy Plan 19: 177-182.
12. Goodman C, Brieger W, Unwin A, Mills A, Meek S, et al. (2007) Medicine sellers and malaria treatment in Sub-Saharan Africa: What do they do and how can their practice be improved? The American Journal of Tropical Medicine and Hygiene 77: 203-218.
13. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A, (2007) Drug shop regulation and malaria treatment in Tanzania- why do shops break the rules, and does it matter? Health Policy Plan 22: 393-403.
14. Onwujekwe O, Uzochukwu B, Eze S, Obikeze E, Okoli C, et al. (2008) Improving equity in malaria treatment: Relationship of socio-economic status with health seeking as well as with perceptions of ease of using the services of different providers for the treatment of malaria in Nigeria. Malaria Journal 7: 5.
15. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, et al. (2004) Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health 9: 655-663.
16. Hetzel MW, Iteba N, Makemba A, Mshana C, Lengeler C, et al. (2007) Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Malar J 6: 83.
17. Federal Ministry of Health (2006) A 5- year Strategic Plan: 2006-2010- A road map for impact on malaria in Nigeria. In: National Malaria Control Programme, editor. Abuja: Federal Ministry of Health, Nigeria.
18. Foster SD, (1991) Pricing, distribution, and use of antimalarial drugs. Bull World Health Organ 69: 349-363.
19. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
20. Kachur SP, Black C, Abdulla S, Goodman C, (2006) Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Malar J 5: 25.
21. Buabeng KO, Duwiejua M, Matowe LK, Smith F, Enlund H, (2008) Availability and choice of antimalarials at medicine outlets in Ghana: The question of access to effective medicines for malaria control. Clinical Pharmacology and Therapeutics 84: 613-619.
22. Marsh V, Mutemi W, Willetts A, Bayah K, Were S, et al. (2004) Improving malaria home treatment by training drug retailers in rural Kenya. Trop Med Int Health 9: 451-460.
23. Palafox B, Patouillard E, Tougher S, Goodman C, Hanson K, (2009) The private commercial sector distribution chain for antimalarial drugs in Nigeria: Findings from a rapid survey. ACTwatch & London School of Hygiene and Tropical Medicine.
24. Valadez JJ, Weld L, Vargas WV, (1995) Monitoring community health workers' performance through lot quality-assurance sampling. Am J Public Health 85: 1165-1166.
25. Valadez JJ, Transgrud R, Mbugua M, Smith T, (1997) Assessing family planning service-delivery skills in Kenya. Studies in Family Planning 28: 143-150.
26. Valadez JJ, Brown LD, Vargas WV, Morley D, (1996) Using lot quality assurance sampling to assess measurements for growth monitoring in a developing country's primary health care system. Int J Epidemiol 25: 381-387.
27. The World Bank (2006) Project Appraisal Document On Proposed Credit In The Amount Of SDR 121.70 Million (US$180 Million Equivalent) To The Federal Republic Of Nigeria For A Malaria Control Booster Project. Washington DC.
28. Mangham LJ, Cundill B, Ezeoke O, Nwala E, Uzochukwu BS, et al. (2011) Treatment of uncomplicated malaria at public health facilities and medicine retailers in south-eastern Nigeria. Malar J 10: 155.
29. Valadez JJ (1991) Assessing child survival programmes in developing countries: testing lot quality assurance sampling. Boston: Harvard University Press.
30. Dodge HF, Romig HG, (1929) A method of sampling inspection. Bell Syst Tech J 8: 398.
31. Robertson SE, Valadez JJ, (2006) Global review of health care surveys using lot quality assurance sampling (LQAS), 1984-2004. Soc Sci Med 63: 1648-1660.
32. CSTS+ (2006) Rapid Health Facility Assessment 2.1 (R-HFA). Child Survival Technical Support (CTCS+) Project.
33. National Malaria Control Program (2009) Detailed Implementation Plan for a Health Facility Assessment in 9 states. Abuja: Federal Ministry of Health.
34. Brixton Health LQAS Sampling Plan Calculator (Hypergeometric model) Brixton Health. Available: http://www.brixtonhealth.com/hyperLQAS.findD.html. Accessed on 28 June 2012.
35. Berenson M LD, Krehbiel T. (2007) Confidence Interval Estimation. Basic Business Statistics. 11 ed: Pearson Education.
36. Oladepo O, Salami KK, Adeoye BW, Oshiname F, Ofi B, et al. (2007) Malaria treatment and policy in three regions in Nigeria: The role of patent medicine vendors Future Health Systems, Innovations for equity. 1 1. 1-26 p.
37. ACT Watch (2008) Outlet Survey Report (Baseline) Federal Republic of Nigeria 12/08. Abuja, Nigeria.
38. Federal Ministry of Health (2011) Federal Republic of Nigeria: National Policy on Malaria Diagnosis and Treatment. Federal Ministry of Health, Abuja, Nigeria.
39. Pharmacists council of Nigeria (2003) Approved patent medicine list. Pharmacy Council of Nigeria.
40. Gilpin U, Adedaji W, Nwokolo E, Akinpelumi A, Anuoyo N, et al. (2006) Artemisinin Combination Therapy (ACTs): Improving Management of Malaria among Patent Medicine Vendors (PMVs) in Lagos, Kano and Abia. StatesTechnical Report. Lagos: Society for Family Health.
41. Wongsrichanalai C, Meshnick SR, (2008) Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis 14: 716-719.
42. Onwujekwe O, Kaur H, Dike N, Shu E, Uzochukwu B, et al. (2009) Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malaria Journal 8: 22.
43. Greer G, Akinpelumi A, Madueke L, Plowman B, Fapohunda B,et al. (2004) Improving management of childhood malaria in Nigeria and Uganda by improving practices of patent medicine vendors. Arlington, VA.
44. Brugha R, Zwi A, (1998) Improving the quality of private sector delivery of public health services: challenges and strategies. Health Policy Plan 13: 107-120.
45. The Global Fund to Fight AIDS Tuberculosis and Malaria (2012) Affordable Medicines Facility- Malaria: First-line buyers of ACT. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria.
46. National Malaria Control Programme (2011) Implementation Guide for Parasite-Based Diagnosis of Malaria. Federal Ministry of Health.
47. Henderson RH, Sundaresan T, (1982) Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 60: 253-260.
48. Valadez J, Devkota BR (2002) Decentralized supervision of community health programs: Using LQAS in two districts of Southern Nepal. Community based health care: Lessons from Bangladesh to Boston: Management Sciences for Health, Inc.
49. Punith K, Lalitha K, Suman G, Pradeep BS, Jayanth Kumar K, (2008) Evaluation of primary immunization coverage of infants under universal immunization programme in an urban area of Bangalore city using cluster sampling and lot quality assurance sampling techniques. Indian J Community Med 33: 151-155.
50. Brooker S, Kabatereine NB, Myatt M, Russell Stothard J, Fenwick A, (2005) Rapid assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the Lot Quality Assurance Sampling method in Uganda. Trop Med Int Health 10: 647-658.
51. Biedron C, Pagano M, Hedt BL, Kilian A, Ratcliffe A, et al. (2010) An assessment of Lot Quality Assurance Sampling to evaluate malaria outcome indicators: extending malaria indicator surveys. Int J Epidemiol 39: 72-79.
52. Robertson SE, Anker M, Roisin AJ, Macklai N, Engstrom K, et al. (1997) The lot quality technique: a global review of applications in the assessment of health services and disease surveillance. World health statistics quarterly 50: 199-209.
53. Brugha R, Chandramohan D, Zwi A, (1999) Viewpoint: management of malaria- working with the private sector. Trop Med Int Health 4: 402-406.
54. Okeke TA, Uzochukwu BS, (2009) Improving childhood malaria treatment and referral practices by training patent medicine vendors in rural south-east Nigeria. Malar J 8: 260.
55. Abuya TO, Fegan G, Amin AA, Akhwale WS, Noor AM, et al. (2010) Evaluating different dimensions of programme effectiveness for private medicine retailer malaria control interventions in Kenya. PLoS One 5: e8937.